{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7497,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a before-and-after medical imaging comparison to demonstrate drug efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/20",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-20",
      "loopMatches": [
        {
          "to": 21,
          "from": 8,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d33db2f2-b823-454e-bb8a-d3c7565f8111",
          "evidence": "The traction section on pages 8-21 highlights quick wins and big bets.",
          "position": 1,
          "objective": "Showcase quick wins and big bets in CAB development",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        },
        {
          "to": 21,
          "from": 11,
          "name": "Voice Of Customer",
          "slug": "51-voice-of-customer",
          "bestFor": "Product strategy, customer experience, market research",
          "matchId": "6accda1b-f475-4991-8a77-17e1fdfaad42",
          "evidence": "Clinical trial results on pages 11-21 demonstrate customer benefit.",
          "position": 2,
          "objective": "Provide evidence of customer (patient) benefit",
          "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
          "confidence": 0.6,
          "description": "Let customer quotes and feedback drive the narrative and validate the insight"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "4a9f5223-f601-412c-b3bc-2e7d0fdbbb91",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction section spans pages 11-21, showcasing clinical trial results and progress.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The table tracks 3 patients across different cancer types, detailing their age, prior treatments, adverse events, dose-limiting toxicities (DLT), cycles completed, response, and current disposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/21",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-21",
      "loopMatches": [
        {
          "to": 21,
          "from": 8,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d33db2f2-b823-454e-bb8a-d3c7565f8111",
          "evidence": "The traction section on pages 8-21 highlights quick wins and big bets.",
          "position": 1,
          "objective": "Showcase quick wins and big bets in CAB development",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        },
        {
          "to": 21,
          "from": 11,
          "name": "Voice Of Customer",
          "slug": "51-voice-of-customer",
          "bestFor": "Product strategy, customer experience, market research",
          "matchId": "6accda1b-f475-4991-8a77-17e1fdfaad42",
          "evidence": "Clinical trial results on pages 11-21 demonstrate customer benefit.",
          "position": 2,
          "objective": "Provide evidence of customer (patient) benefit",
          "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
          "confidence": 0.6,
          "description": "Let customer quotes and feedback drive the narrative and validate the insight"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 11,
          "beatId": "4a9f5223-f601-412c-b3bc-2e7d0fdbbb91",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction section spans pages 11-21, showcasing clinical trial results and progress.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to map patient segments to specific dosing regimens and clinical goals.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/22",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/23",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a 2x2 grid of metrics to frame the problem/opportunity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/24",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes comparative context to historical studies (pazopanib, pembrolizumab).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/25",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes decision criteria for 'Go'/'No Go' based on clinical response and PFS rates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/26",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes specific adverse event data and clinical observations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/27",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "Details specific patient enrollment numbers (~80 total, ~60 for primary analysis) and dosing randomization criteria.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/28",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a grid of metrics to define the addressable market and the clinical problem (progression after 1L).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/29",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 29,
          "from": 24,
          "beatId": "9bcd5a0a-740c-4853-97bc-75472d60fcdf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": null,
          "evidence": "Market sizing and potential opportunities are discussed on pages 24-29.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide presents clinical evidence linking AXL expression to poor patient outcomes in two different cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/30",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-30",
      "loopMatches": [
        {
          "to": 30,
          "from": 30,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "fa596b49-ad10-48ec-b55e-be7efa8d3736",
          "evidence": "The problem statement on page 30 implies the cost of inaction.",
          "position": 0,
          "objective": "Highlight the cost of inaction in cancer therapy",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 30,
          "beatId": "c41c7a02-9893-4d75-b19b-128a0ec29ee5",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The problem is clearly stated on page 30, highlighting the limitations of current cancer therapies.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide outlines a clinical trial protocol including patient disposition criteria and study endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/31",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table highlights the heavy pretreatment status of the patient population, specifically noting that a significant portion received 3 or more prior systemic therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/32",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes specific response rates, disease control rates, and confidence intervals for two patient cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/33",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Waterfall plot shows best percentage change from baseline; spider plot shows change over time in weeks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/34",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "This is a classic swimmer plot used in oncology clinical trials to visualize time-on-treatment and response status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/35",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "product_demo",
      "function": "show_traction",
      "notes": "Includes PET scan imagery comparing baseline to post-treatment status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/36",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented at IASLC 2023 North America Conference on Lung Cancer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/37",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut date: 30Jun23. Includes events occurring in >=15% of patients or grade >=3 in >=3% of patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/38",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Mentions FDA Project Optimus, which is a regulatory initiative for dose optimization in oncology trials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/39",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The dashed box highlights the 'AXL low' expression group, showing significant anti-tumor activity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/40",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/41",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/42",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "Includes footnotes for data sources and a glossary of terms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/43",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart is a waterfall plot showing percentage change in tumor size. Red bars indicate partial response (PR).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/44",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "Uses a 2x2 grid layout to present key market metrics alongside current treatment efficacy benchmarks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/45",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes specific patient counts and clinical outcomes (responses, stable disease, progressive disease).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/46",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a funnel-like logic to narrow down the addressable market from total prevalence to the 2L+ refractory segment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/47",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a table to present clinical outcomes for specific cancer types, followed by a summary statement on the first-in-class status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/48",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9434-73df-8e70-401e13bb3d65",
      "docSlug": "692690be0ea25b83b6a4c7490ff14999",
      "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
      "authorId": "bioatla",
      "authorName": "BioAtla",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays specific drug administration schedules for clinical evaluation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/49",
      "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
      "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}